Racial differences in long-term adjuvant endocrine therapy adherence and mortality among Medicaid-insured breast cancer patients in Texas: Findings from TCR-Medicaid linked data

Documenti analoghi

• Racial and geographic disparities in adherence and discontinuation to adjuvant endocrine therapy in Texas Medicaid-insured patients with breast cancer
  di: Farias, Albert J., et al.
  Pubblicazione: (2018)
• Racial differences in adjuvant endocrine therapy use and discontinuation in association with mortality among Medicare breast cancer patients by receptor status
  di: Farias, Albert J., et al.
  Pubblicazione: (2017)
• Association Between Out-Of-Pocket Costs, Race/Ethnicity, and Adjuvant Endocrine Therapy Adherence Among Medicare Patients With Breast Cancer
  di: Farias, Albert J., et al.
  Pubblicazione: (2017)
• Ethnic differences in initiation and timing of adjuvant endocrine therapy among older women with hormone receptor-positive breast cancer enrolled in Medicare Part D
  di: Farias, Albert J., et al.
  Pubblicazione: (2016)
• Factors Associated with Adherence to Adjuvant Endocrine Therapy Among Privately Insured and Newly Diagnosed Breast Cancer Patients: A Quantile Regression Analysis
  di: Farias, Albert J., et al.
  Pubblicazione: (2016)